MARIA WILSON: Open Payments
NPI 1487790150 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,346 in 50 payments from 15 companies in 2025. Trend: 2023 $1,133 · 2024 $1,204 · 2025 $1,346
Food & beverage: $1,346
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 15 | $391 |
| Boston Scientific Corporation | 5 | $260 |
| Averitas Pharma Inc. | 5 | $149 |
| Abbott Laboratories | 5 | $102 |
| TerSera Therapeutics LLC | 2 | $77 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Globus Medical, Inc. | 2 | $43 |
| MML US, Inc. | 1 | $28 |
Products named: Evoke, WaveWriter Alpha Prime 16, QUTENZA, PROCLAIM, Prialt, JOURNAVX, RELISTOR, Senza.
Industry payments across MD — which companies pay providers there.
